GC
SRNE

GFG Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

GFG Capital’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-54,000
Closed -$126K – 162
2022
Q1 		$126K Buy
54,000
+27,200
+101% +$63.5K 0.04% 147
2021
Q4 		$125K Hold
26,800
– – 0.04% 145
2021
Q3 		$204K Buy
+26,800
New +$204K 0.06% 124